• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • NMPA Monthly Newsletter

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

China NMPA Newsletter – April 2024

2024-05-12

Featured Articles NMPA New Approvals in March 2024 In March 2024, NMPA approved 325 medical devices, including 29 Class III…

NMPA New Approvals In March 2024

2024-04-27

In March 2024, NMPA approved 325 medical devices, including 29 Class III imported products, 30 Class II imported…

China NMPA Medical Device Review Center Issues Notice On The Release Of Clinical Evaluation Recommended Paths For Products In The Medical Device Classification Catalog (2024 Supplement) – Notice No. 11 Of 2024

2024-04-27

In order to further guide applicants in determining the specific clinical evaluation paths for their registration, the Medical…

China NMPA Newsletter – March 2024

2024-04-02

Featured Articles NMPA New Approvals in February 2024 In February 2024, NMPA approved 193 medical devices, including 21…

CT Angiography Software For Intracranial Aneurysm Detection Approved By China NMPA

2024-03-26

In March 2024, the China NMPA approved an innovative product registration application for a CT angiography software designed…

Disposable Cardiac Pulse Field Ablation Catheter Approved By China NMPA

2024-03-26

On March 11, 2024, the China NMPA approved an innovative product registration application for a disposable cardiac pulse…

NMPA New Approvals In February 2024

2024-03-18

In February 2024, NMPA approved 193 medical devices, including 21 Class III imported products, 22 Class II imported…

China NMPA Newsletter – February 2024

2024-03-04

  Featured Articles NMPA New Approvals in January 2024 In January 2024, NMPA approved 321 medical devices, including…

China NMPA Released Plan For Annual Medical Device Quality Inspections

2024-02-28

As the annual China NMPA medical device quality inspections gear up from March to April, lasting until the…

China NMPA Newsletter – January 2024

2024-02-26

Featured Articles NMPA New Approvals in December 2023 In December 2023, NMPA approved 343 medical devices, including 37…

NMPA New Approvals In January2024

2024-02-26

In January 2024, NMPA approved 321 medical devices, including 41 Class III imported products, 33 Class II imported…

Summary Of 2023 China NMPA Medical Device Registration Work Report

2024-02-26

NMPA has summarized its work on all medical devices in 2023, which includes medical device registrations, acceptance of…
Prev12345...81012...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7